- Home
- GHG vs ACIU Comparison
GHG vs ACIU Comparison
Compare GHG & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHG
- ACIU
- Stock Information
- Founded
- GHG 2004
- ACIU 2003
- Country
- GHG China
- ACIU Switzerland
- Employees
- GHG N/A
- ACIU N/A
- Industry
- GHG Hotels/Resorts
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- GHG Consumer Discretionary
- ACIU Health Care
- Exchange
- GHG Nasdaq
- ACIU Nasdaq
- Market Cap
- GHG 259.8M
- ACIU 332.4M
- IPO Year
- GHG 2018
- ACIU 2016
- Fundamental
- Price
- GHG $2.50
- ACIU $2.68
- Analyst Decision
- GHG
- ACIU Strong Buy
- Analyst Count
- GHG 0
- ACIU 2
- Target Price
- GHG N/A
- ACIU $12.00
- AVG Volume (30 Days)
- GHG 13.0K
- ACIU 132.5K
- Earning Date
- GHG 02-25-2025
- ACIU 11-05-2024
- Dividend Yield
- GHG 4.00%
- ACIU N/A
- EPS Growth
- GHG N/A
- ACIU N/A
- EPS
- GHG 0.28
- ACIU N/A
- Revenue
- GHG $201,166,731.00
- ACIU $48,505,404.00
- Revenue This Year
- GHG N/A
- ACIU $85.33
- Revenue Next Year
- GHG $8.78
- ACIU $80.69
- P/E Ratio
- GHG $8.99
- ACIU N/A
- Revenue Growth
- GHG N/A
- ACIU 4097200.00
- 52 Week Low
- GHG $2.31
- ACIU $2.25
- 52 Week High
- GHG $4.10
- ACIU $5.14
- Technical
- Relative Strength Index (RSI)
- GHG 41.31
- ACIU 27.49
- Support Level
- GHG $2.39
- ACIU $2.62
- Resistance Level
- GHG $2.71
- ACIU $3.02
- Average True Range (ATR)
- GHG 0.10
- ACIU 0.15
- MACD
- GHG -0.01
- ACIU -0.05
- Stochastic Oscillator
- GHG 26.83
- ACIU 9.52
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.